Trial intelligence / Profile preview

R-CHOP or BR plus zanubrutinib as first-line therapy in young mantle cell lymphoma

ChiCTR2200055483Phase 4Recruiting

Sponsor

First Affiliated Hospital of Soochow University

Start

Dec 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1